Stay updated on Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Footer now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This update reflects a page revision and does not affect the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-11T17:59:11.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, indicating a new build of the page.
    Difference
    0.0%
    Check dated 2026-07-28T14:41:12.000Z thumbnail image
  4. Check
    21 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The revision label in the study documents section was updated from v3.6.0 to v3.6.3, indicating a newer version of the protocol/document referenced on the page.
    Difference
    0.0%
    Check dated 2026-06-30T01:08:42.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page gains new navigation items such as No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment, along with a revision tag for v3.6.0. The older heading Intervention / Treatment and the v3.5.5 revision were removed.
    Difference
    0.4%
    Check dated 2026-06-15T14:51:12.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4.
    Difference
    0.0%
    Check dated 2026-06-08T15:16:03.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4 in place of Revision: v3.5.3, indicating a new site software release. This update affects page labeling but not the underlying study information.
    Difference
    0.0%
    Check dated 2026-05-18T03:49:31.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.